Piper Sandler analyst James Fish lowered the firm’s price target on Nutanix (NTNX) to $63 from $72 and keeps an Overweight rating on the shares. With a 2% beat and only $20M FY26 top-line guide cut, shares are pointed 15% higher as fears of a larger cut were overblown, the firm says. While a cut is never something Piper likes to see, and caused by macro-factors and not execution, the firm is encouraged by the highest net-new customer additions in 8 years, TCV bookings growing mid-teens and outpacing revenue growth this year, contribution from OEM partners, and the new AMD (AMD) partnership.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix price target lowered to $60 from $75 at BofA
- Nutanix: Buy Rating Reaffirmed on Strong Bookings Outlook, Strategic AMD AI Partnership, and Attractive Valuation Despite Near‑Term Headwinds
- Nutanix price target lowered to $53 from $56 at Morgan Stanley
- Nutanix price target raised to $60 from $57 at UBS
- Nutanix price target lowered to $50 from $57 at Wells Fargo
